Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case informationLast updated

GeneDx Securities Fraud Class Action

GeneDx Holdings Corp. · GeneDx genetic testing services and GeneDx common stock · Ongoing Litigation

About this case

A federal securities class action alleges that GeneDx Holdings and its executives made false or misleading statements or failed to disclose information concerning the importance of its Fabric Genomics acquisition, reimbursement rates, and expected gross margins, causing investor losses when the company disclosed disappointing results and reduced guidance. The lawsuit was filed, and the deadline to seek appointment as lead plaintiff was August 3, 2026; its current litigation status is otherwise not specified.

Case overview

Defendant company
GeneDx Holdings Corp.
Product or service
GeneDx genetic testing services and GeneDx common stock
Case name
Taher Basma v. GeneDx Holdings Corp.
Court case number
26-cv-00880 (D. Conn.)
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

GeneDx Holdings Lead Plaintiff Application

Participation information

GeneDx Holdings Lead Plaintiff Application

Investors who purchased or acquired GeneDx Holdings stock between April 16, 2025 and May 4, 2026 and suffered financial losses were described as potential lead-plaintiff applicants.

Eligible investors could seek appointment as lead plaintiff through counsel of their choice by moving the court before the August 3, 2026 deadline. That deadline has passed.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear
Apply as lead plaintiff Apply as lead plaintiff Apply as lead plaintiff Apply as lead plaintiff Apply as lead plaintiff Apply as lead plaintiff
Case announcement Original article

Sources